Breaking News Instant updates and real-time market news.

TWI

Titan International

$8.24 /

+0.29 (+3.65%)

12:55
03/04/21
03/04
12:55
03/04/21
12:55

Titan International CEO sees 'noticeable EBITDA improvement' in 2021

"The positive trends that we saw late in 2020 have only increased during the first few months of 2021. We expect this favorable trend in South America to continue along with North America demand accelerating through 2021 due to strong farmer income and commodity prices combined with low levels of inventory in many channels. Along with market improvements, we are seeing an improved pricing environment. In the first quarter of 2021, we have increased prices to offset rising raw material costs. We will continue to increase prices to offset higher production costs, and as the year progresses, we expect to improve our pricing leverage to manage our gross margins. With the business trending positively in many ways, we are looking toward a noticeable EBITDA improvement in 2021. The market has shifted positively so quickly in a relatively short time period making it difficult to provide a reasonable full-year 2021 forecast for sales and EBITDA. We do expect our 2021 capital expenditures to be in the range from $35 million to $40 million with continued flexibility based upon cash flow. With continued working capital focus and similar interest levels as 2020, we expect the full year to end cash flow positive. We also expect that we can improve our payment terms with customers to offset the impact on working capital from the growth in sales," stated Titan International president and CEO Paul Reitz earlier this morning.

  • 04

    Mar

TWI Titan International
$8.24 /

+0.29 (+3.65%)

01/15/21 Jefferies
Titan International price target raised to $7.50 from $4 at Jefferies

TODAY'S FREE FLY STORIES

Hot Stocks
Pfizer can deliver 10% more vaccine doses to U.S. by end of May, says CEO » 16:25
04/13/21
04/13
16:25
04/13/21
16:25
PFE

Pfizer

$37.15 /

+0.17 (+0.46%)

, BNTX

BioNTech

$129.64 /

+8.13 (+6.69%)

Pfizer (PFE) chairman and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$37.15 /

+0.17 (+0.46%)

BNTX BioNTech
$129.64 /

+8.13 (+6.69%)

PFE Pfizer
$37.15 /

+0.17 (+0.46%)

09:33 Today Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
09:21 Today JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
04/09/21
Pfizer to host conference call
04/06/21 RBC Capital
Pfizer transferred with a Sector Perform at RBC Capital
BNTX BioNTech
$129.64 /

+8.13 (+6.69%)

02/23/21 B. Riley Securities
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
PFE Pfizer
$37.15 /

+0.17 (+0.46%)

  • 23
    Jul
PFE Pfizer
$37.15 /

+0.17 (+0.46%)

BNTX BioNTech
$129.64 /

+8.13 (+6.69%)

PFE Pfizer
$37.15 /

+0.17 (+0.46%)

BNTX BioNTech
$129.64 /

+8.13 (+6.69%)

PFE Pfizer
$37.15 /

+0.17 (+0.46%)

BNTX BioNTech
$129.64 /

+8.13 (+6.69%)

Initiation
MAG Silver initiated with a Neutral at CIBC » 16:25
04/13/21
04/13
16:25
04/13/21
16:25
MAG

MAG Silver

$17.05 /

+0.27 (+1.61%)

CIBC initiated coverage…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MAG MAG Silver
$17.05 /

+0.27 (+1.61%)

MAG MAG Silver
$17.05 /

+0.27 (+1.61%)

02/08/21 Stifel
MAG Silver price target raised to C$29 from C$27.75 at Stifel
01/28/21 BMO Capital
MAG Silver price target lowered to C$22.50 from C$23.50 at BMO Capital
01/15/21 Raymond James
MAG Silver price target raised to C$29 from C$26 at Raymond James
01/11/21 National Bank
MAG Silver price target raised to C$35 from C$29.50 at National Bank
MAG MAG Silver
$17.05 /

+0.27 (+1.61%)

Initiation
Gatos Silver initiated with an Outperformer at CIBC » 16:23
04/13/21
04/13
16:23
04/13/21
16:23
GATO

Gatos Silver

$10.19 /

+0.49 (+5.05%)

CIBC initiated coverage…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GATO Gatos Silver
$10.19 /

+0.49 (+5.05%)

GATO Gatos Silver
$10.19 /

+0.49 (+5.05%)

01/29/21 BMO Capital
Gatos Silver downgraded to Market Perform from Outperform at BMO Capital
11/24/20 BMO Capital
Gatos Silver initiated with an Outperform at BMO Capital
11/23/20 RBC Capital
Gatos Silver initiated with an Outperform at RBC Capital
  • 28
    Oct
GATO Gatos Silver
$10.19 /

+0.49 (+5.05%)

GATO Gatos Silver
$10.19 /

+0.49 (+5.05%)

Upgrade
Snap upgraded to Outperform upon assumption at Wedbush » 16:21
04/13/21
04/13
16:21
04/13/21
16:21
SNAP

Snap

$62.44 /

+ (+0.00%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SNAP Snap
$62.44 /

+ (+0.00%)

SNAP Snap
$62.44 /

+ (+0.00%)

16:12 Today Wedbush
Snap assumed at Outperform from Neutral at Wedbush
04/06/21 Atlantic Equities
Snap upgraded to Overweight from Neutral at Atlantic Equities
04/05/21 Evercore ISI
Snap assumed with an Outperform at Evercore ISI
03/31/21 Wolfe Research
Snap initiated with an Outperform at Wolfe Research
SNAP Snap
$62.44 /

+ (+0.00%)

SNAP Snap
$62.44 /

+ (+0.00%)

SNAP Snap
$62.44 /

+ (+0.00%)

SNAP Snap
$62.44 /

+ (+0.00%)

Earnings
Nurix Therapeutics reports Q1 EPS (63c), consensus (46c) » 16:21
04/13/21
04/13
16:21
04/13/21
16:21
NRIX

Nurix Therapeutics

$26.44 /

-0.065 (-0.25%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NRIX Nurix Therapeutics
$26.44 /

-0.065 (-0.25%)

NRIX Nurix Therapeutics
$26.44 /

-0.065 (-0.25%)

02/17/21 Piper Sandler
Nurix Therapeutics price target raised to $60 from $40 at Piper Sandler
02/16/21 Piper Sandler
Nurix Therapeutics price target raised to $60 from $40 at Piper Sandler
01/29/21 JPMorgan
Nurix Therapeutics price target raised to $56 from $34 at JPMorgan
11/24/20 Morgan Stanley
Kymera Therapeutics price target raised to $45 from $27 at Morgan Stanley
NRIX Nurix Therapeutics
$26.44 /

-0.065 (-0.25%)

  • 05
    Mar
  • 24
    Jul
NRIX Nurix Therapeutics
$26.44 /

-0.065 (-0.25%)

Hot Stocks
Procter & Gamble raises quarterly dividend 10% to 86.98c per share » 16:21
04/13/21
04/13
16:21
04/13/21
16:21
PG

Procter & Gamble

$135.12 /

-1.78 (-1.30%)

The Board of Directors of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PG Procter & Gamble
$135.12 /

-1.78 (-1.30%)

PG Procter & Gamble
$135.12 /

-1.78 (-1.30%)

03/02/21 BofA
Procter & Gamble removed from the US 1 List at BofA
01/28/21 Stifel
Stifel downgrades Procter & Gamble to Hold on emerging headwinds
01/28/21 Stifel
Procter & Gamble downgraded to Hold from Buy at Stifel
01/19/21 Bernstein
Procter & Gamble initiated with a Market Perform at Bernstein
PG Procter & Gamble
$135.12 /

-1.78 (-1.30%)

PG Procter & Gamble
$135.12 /

-1.78 (-1.30%)

PG Procter & Gamble
$135.12 /

-1.78 (-1.30%)

PG Procter & Gamble
$135.12 /

-1.78 (-1.30%)

Hot Stocks
ProQR Therapeutics announces journal publication on sepofarsen trial » 16:20
04/13/21
04/13
16:20
04/13/21
16:20
PRQR

ProQR Therapeutics

$6.01 /

+0.05 (+0.84%)

ProQR Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRQR ProQR Therapeutics
$6.01 /

+0.05 (+0.84%)

PRQR ProQR Therapeutics
$6.01 /

+0.05 (+0.84%)

03/25/21 Citi
ProQR Therapeutics price target raised to $44 from $33 at Citi
03/24/21 Cantor Fitzgerald
ProQR Therapeutics price target raised to $33 from $22 at Cantor Fitzgerald
03/24/21 JMP Securities
ProQR Therapeutics price target raised to $35 from $19 at JMP Securities
11/02/20 Cantor Fitzgerald
ProQR Therapeutics assumed with an Overweight at Cantor Fitzgerald
PRQR ProQR Therapeutics
$6.01 /

+0.05 (+0.84%)

  • 31
    Mar
PRQR ProQR Therapeutics
$6.01 /

+0.05 (+0.84%)

Options
Closing CBOE SPX and VIX Index summary for April 13th » 16:20
04/13/21
04/13
16:20
04/13/21
16:20
VIX

Volatility Index S&P 500 Options

/

+

The CBOE Volatility Index…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VIX Volatility Index S&P 500 Options
/

+

Upgrade
Nihon Kohden upgraded to Overweight from Equal Weight at Morgan Stanley » 16:19
04/13/21
04/13
16:19
04/13/21
16:19
NHNKY

Nihon Kohden

$14.29 /

-0.26 (-1.79%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NHNKY Nihon Kohden
$14.29 /

-0.26 (-1.79%)

02/10/21 Daiwa
Nihon Kohden downgraded to Neutral from Outperform at Daiwa
01/07/21 Mizuho
Nihon Kohden downgraded to Neutral from Buy at Mizuho
Hot Stocks
Shore Bancshares announces new branch in South Ocean City, Maryland » 16:19
04/13/21
04/13
16:19
04/13/21
16:19
SHBI

Shore Bancshares

$17.00 /

-0.04 (-0.23%)

Shore Bancshares…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SHBI Shore Bancshares
$17.00 /

-0.04 (-0.23%)

SHBI Shore Bancshares
$17.00 /

-0.04 (-0.23%)

03/08/21 Keefe Bruyette
Shore Bancshares upgraded to Outperform from Market Perform at Keefe Bruyette
SHBI Shore Bancshares
$17.00 /

-0.04 (-0.23%)

Hot Stocks
Results in Endo's phase 3 study show meaningful improvement in severe cellulite » 16:19
04/13/21
04/13
16:19
04/13/21
16:19
ENDP

Endo

$6.11 /

-0.07 (-1.13%)

The company states:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ENDP Endo
$6.11 /

-0.07 (-1.13%)

ENDP Endo
$6.11 /

-0.07 (-1.13%)

04/06/21 RBC Capital
Endo transferred with a Sector Perform at RBC Capital
03/08/21 Barclays
Endo price target raised to $7 from $6 at Barclays
03/04/21 Citi
Endo price target lowered to $10 from $11 at Citi
01/19/21 Citi
Endo price target raised to $9 from $7 at Citi
ENDP Endo
$6.11 /

-0.07 (-1.13%)

ENDP Endo
$6.11 /

-0.07 (-1.13%)

ENDP Endo
$6.11 /

-0.07 (-1.13%)

ENDP Endo
$6.11 /

-0.07 (-1.13%)

Hot Stocks
Stitch Fix CEO Lake to transition to executive chairperson role » 16:18
04/13/21
04/13
16:18
04/13/21
16:18
SFIX

Stitch Fix

$49.46 /

-1.3 (-2.56%)

Stitch Fix, Inc.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SFIX Stitch Fix
$49.46 /

-1.3 (-2.56%)

SFIX Stitch Fix
$49.46 /

-1.3 (-2.56%)

04/05/21 Evercore ISI
Stitch Fix initiated with an Outperform at Evercore ISI
03/09/21
Fly Intel: Top five analyst downgrades
03/09/21 Canaccord
Stitch Fix price target lowered to $68 from $72 at Canaccord
03/09/21 KeyBanc
Stitch Fix price target lowered to $75 from $95 at KeyBanc
SFIX Stitch Fix
$49.46 /

-1.3 (-2.56%)

SFIX Stitch Fix
$49.46 /

-1.3 (-2.56%)

SFIX Stitch Fix
$49.46 /

-1.3 (-2.56%)

Earnings
Flexion sees FY21 revenue $120M-$130M, consensus $137.42M » 16:18
04/13/21
04/13
16:18
04/13/21
16:18
FLXN

Flexion

$9.37 /

+1.05 (+12.62%)

FY21 total operating…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FLXN Flexion
$9.37 /

+1.05 (+12.62%)

FLXN Flexion
$9.37 /

+1.05 (+12.62%)

04/06/21 RBC Capital
Flexion transferred with an Outperform at RBC Capital
08/20/20 Goldman Sachs
Flexion initiated with a Neutral at Goldman Sachs
07/30/20 Oppenheimer
Flexion initiated with an Outperform at Oppenheimer
07/29/20
Fly Intel: Top five analyst initiations
FLXN Flexion
$9.37 /

+1.05 (+12.62%)

  • 21
    May
Downgrade
Facebook assumed with Neutral at Wedbush, cites privacy risk » 16:17
04/13/21
04/13
16:17
04/13/21
16:17
FB

Facebook

$309.74 /

-1.96 (-0.63%)

, AAPL

Apple

$134.41 /

+3.14 (+2.39%)

Wedbush analyst Ygal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FB Facebook
$309.74 /

-1.96 (-0.63%)

AAPL Apple
$134.41 /

+3.14 (+2.39%)

FB Facebook
$309.74 /

-1.96 (-0.63%)

16:09 Today Wedbush
Facebook assumed at Neutral from Outperform at Wedbush
04/05/21 Evercore ISI
Facebook assumed with an Outperform at Evercore ISI
03/31/21 Wolfe Research
Facebook initiated with an Outperform at Wolfe Research
03/29/21 Deutsche Bank
Facebook price target raised to $385 from $355 at Deutsche Bank
AAPL Apple
$134.41 /

+3.14 (+2.39%)

04/12/21 Canaccord
Canaccord upgrades Tesla with over $1,000 target on 'Apple-esque' ecosystem
04/09/21 Citi
Citi tells investors to focus on Apple's capital deployment, iPhone gains
04/08/21 Piper Sandler
Teen iPhone ownership continues to increase, says Piper Sandler
04/06/21 Cowen
Apple's News product a key growth pillar, says Cowen
FB Facebook
$309.74 /

-1.96 (-0.63%)

AAPL Apple
$134.41 /

+3.14 (+2.39%)

FB Facebook
$309.74 /

-1.96 (-0.63%)

AAPL Apple
$134.41 /

+3.14 (+2.39%)

FB Facebook
$309.74 /

-1.96 (-0.63%)

AAPL Apple
$134.41 /

+3.14 (+2.39%)

FB Facebook
$309.74 /

-1.96 (-0.63%)

AAPL Apple
$134.41 /

+3.14 (+2.39%)

Earnings
Flexion reports preliminary Q1 revenue $24.6M, consensus $25.23M » 16:17
04/13/21
04/13
16:17
04/13/21
16:17
FLXN

Flexion

$9.37 /

+1.05 (+12.62%)

As of March 31, the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FLXN Flexion
$9.37 /

+1.05 (+12.62%)

FLXN Flexion
$9.37 /

+1.05 (+12.62%)

04/06/21 RBC Capital
Flexion transferred with an Outperform at RBC Capital
08/20/20 Goldman Sachs
Flexion initiated with a Neutral at Goldman Sachs
07/30/20 Oppenheimer
Flexion initiated with an Outperform at Oppenheimer
07/29/20
Fly Intel: Top five analyst initiations
FLXN Flexion
$9.37 /

+1.05 (+12.62%)

  • 21
    May
Recommendations
Organigram price target lowered to C$3.75 from C$4 at Alliance Global Partners » 16:17
04/13/21
04/13
16:17
04/13/21
16:17
OGI

Organigram

$2.92 /

+0.145 (+5.23%)

Alliance Global Partners…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OGI Organigram
$2.92 /

+0.145 (+5.23%)

OGI Organigram
$2.92 /

+0.145 (+5.23%)

04/07/21 BMO Capital
Organigram upgraded to Market Perform from Underperform at BMO Capital
03/16/21 Stifel
Organigram price target raised to C$6 from C$1.90 at Stifel
03/15/21 BMO Capital
Organigram price target raised to C$4 from C$2 at BMO Capital
03/12/21 CIBC
Organigram price target raised to C$5 from C$4.25 at CIBC
OGI Organigram
$2.92 /

+0.145 (+5.23%)

OGI Organigram
$2.92 /

+0.145 (+5.23%)

OGI Organigram
$2.92 /

+0.145 (+5.23%)

OGI Organigram
$2.92 /

+0.145 (+5.23%)

Technical Analysis
NASDAQ market internals summary » 16:17
04/13/21
04/13
16:17
04/13/21
16:17
$NSD

NASDAQ Market Internals

/

+

Volume was above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
/

+

Earnings
PerkinElmer sees Q1 reported revenue growth 98%, consensus $1.19B » 16:16
04/13/21
04/13
16:16
04/13/21
16:16
PKI

PerkinElmer

$135.39 /

+2.695 (+2.03%)

PerkinElmer announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PKI PerkinElmer
$135.39 /

+2.695 (+2.03%)

PKI PerkinElmer
$135.39 /

+2.695 (+2.03%)

02/03/21 Citi
PerkinElmer price target raised to $155 from $150 at Citi
01/07/21 Piper Sandler
Oxford Immunotec downgraded to Neutral from Overweight at Piper Sandler
01/07/21 Wells Fargo
PerkinElmer upgraded to Overweight from Equal Weight at Wells Fargo
01/07/21 Wells Fargo
PerkinElmer upgraded to Overweight from Equal Weight at Wells Fargo
PKI PerkinElmer
$135.39 /

+2.695 (+2.03%)

PKI PerkinElmer
$135.39 /

+2.695 (+2.03%)

Technical Analysis
NYSE market internals summary » 16:16
04/13/21
04/13
16:16
04/13/21
16:16
$NYE

NYSE Market Internals

/

+

Volume was average for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
/

+

Initiation
Twitter assumed with a Neutral at Wedbush » 16:14
04/13/21
04/13
16:14
04/13/21
16:14
TWTR

Twitter

$72.42 /

+1.55 (+2.19%)

Wedbush analyst Ygal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TWTR Twitter
$72.42 /

+1.55 (+2.19%)

TWTR Twitter
$72.42 /

+1.55 (+2.19%)

04/05/21 Evercore ISI
Twitter assumed with an In Line at Evercore ISI
03/31/21 Wolfe Research
Twitter initiated with a Peer Perform at Wolfe Research
03/30/21 Morgan Stanley
Twitter price target lowered to $68 from $75 at Morgan Stanley
03/29/21
Fly Intel: Top five analyst upgrades
TWTR Twitter
$72.42 /

+1.55 (+2.19%)

TWTR Twitter
$72.42 /

+1.55 (+2.19%)

TWTR Twitter
$72.42 /

+1.55 (+2.19%)

TWTR Twitter
$72.42 /

+1.55 (+2.19%)

Hot Stocks
Kura Sushi reports Q2 comparable restaurant sales down 60% » 16:13
04/13/21
04/13
16:13
04/13/21
16:13
KRUS

Kura Sushi

$31.34 /

+0.27 (+0.87%)

Adjusted EBITDA was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KRUS Kura Sushi
$31.34 /

+0.27 (+0.87%)

04/06/21 Craig-Hallum
Kura Sushi price target raised to $40 from $25 at Craig-Hallum
03/04/21 Stephens
Kura Sushi price target raised to $42 from $28 at Stephens
03/03/21 BTIG
Kura Sushi price target raised to $40 from $22 at BTIG
01/12/21 Craig-Hallum
Kura Sushi upgraded to Buy from Hold at Craig-Hallum
KRUS Kura Sushi
$31.34 /

+0.27 (+0.87%)

Initiation
Overstock.com assumed with an Outperform at Wedbush » 16:13
04/13/21
04/13
16:13
04/13/21
16:13
OSTK

Overstock.com

$77.77 /

+5.47 (+7.57%)

Wedbush analyst Ygal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OSTK Overstock.com
$77.77 /

+5.47 (+7.57%)

OSTK Overstock.com
$77.77 /

+5.47 (+7.57%)

04/09/21 Piper Sandler
Piper calls Overstock 'most mispriced stock' with 'tremendous risk/reward'
02/25/21 DA Davidson
Overstock.com price target raised to $121 from $103 at DA Davidson
02/25/21 Wedbush
Overstock.com price target lowered to $100 from $126 at Wedbush
02/25/21 BofA
Overstock.com upgraded to Buy from Neutral at BofA
OSTK Overstock.com
$77.77 /

+5.47 (+7.57%)

  • 12
    Aug
OSTK Overstock.com
$77.77 /

+5.47 (+7.57%)

OSTK Overstock.com
$77.77 /

+5.47 (+7.57%)

OSTK Overstock.com
$77.77 /

+5.47 (+7.57%)

Initiation
Alphabet assumed with Outperform, added to 'Best Ideas' at Wedbush » 16:12
04/13/21
04/13
16:12
04/13/21
16:12
GOOG

Alphabet

$2,270.15 /

+14.75 (+0.65%)

, GOOGL

Alphabet Class A

$2,257.06 /

+12.325 (+0.55%)

Wedbush analyst Ygal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GOOG Alphabet
$2,270.15 /

+14.75 (+0.65%)

GOOGL Alphabet Class A
$2,257.06 /

+12.325 (+0.55%)

GOOG Alphabet
$2,270.15 /

+14.75 (+0.65%)

04/05/21 Evercore ISI
Alphabet assumed with an Outperform at Evercore ISI
04/01/21 Morgan Stanley
Microsoft making progress toward being 'Netflix of Gaming,' says Morgan Stanley
03/31/21 Wolfe Research
Alphabet initiated with an Outperform at Wolfe Research
03/30/21
Fly Intel: Top five analyst upgrades
GOOGL Alphabet Class A
$2,257.06 /

+12.325 (+0.55%)

04/12/21 BMO Capital
Microsoft price target raised to $280 from $270 at BMO Capital
04/09/21 Argus
Alphabet price target raised to $2,500 from $2,400 at Argus
04/05/21 Evercore ISI
Alphabet assumed with an Outperform at Evercore ISI
04/01/21 Morgan Stanley
Microsoft making progress toward being 'Netflix of Gaming,' says Morgan Stanley
GOOG Alphabet
$2,270.15 /

+14.75 (+0.65%)

GOOGL Alphabet Class A
$2,257.06 /

+12.325 (+0.55%)

GOOG Alphabet
$2,270.15 /

+14.75 (+0.65%)

GOOGL Alphabet Class A
$2,257.06 /

+12.325 (+0.55%)

GOOG Alphabet
$2,270.15 /

+14.75 (+0.65%)

GOOGL Alphabet Class A
$2,257.06 /

+12.325 (+0.55%)

GOOG Alphabet
$2,270.15 /

+14.75 (+0.65%)

GOOGL Alphabet Class A
$2,257.06 /

+12.325 (+0.55%)

Earnings
Kura Sushi reports Q2 adjusted EPS (78c), consensus (78c) » 16:12
04/13/21
04/13
16:12
04/13/21
16:12
KRUS

Kura Sushi

$31.34 /

+0.27 (+0.87%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KRUS Kura Sushi
$31.34 /

+0.27 (+0.87%)

04/06/21 Craig-Hallum
Kura Sushi price target raised to $40 from $25 at Craig-Hallum
03/04/21 Stephens
Kura Sushi price target raised to $42 from $28 at Stephens
03/03/21 BTIG
Kura Sushi price target raised to $40 from $22 at BTIG
01/12/21 Craig-Hallum
Kura Sushi upgraded to Buy from Hold at Craig-Hallum
KRUS Kura Sushi
$31.34 /

+0.27 (+0.87%)

Earnings
Bruker sees Q1 revenue $549M-$554M, consensus $506.86M » 16:12
04/13/21
04/13
16:12
04/13/21
16:12
BRKR

Bruker

$69.00 /

+1.46 (+2.16%)

The company states:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BRKR Bruker
$69.00 /

+1.46 (+2.16%)

BRKR Bruker
$69.00 /

+1.46 (+2.16%)

02/17/21 Stifel
Bruker price target raised to $65 from $48 at Stifel
02/17/21 Citi
Bruker price target raised to $65 from $57 at Citi
02/05/21 Wells Fargo
Bruker downgraded to Equal Weight with $55 target at Wells Fargo
02/05/21 Wells Fargo
Bruker downgraded to Equal Weight from Overweight at Wells Fargo
BRKR Bruker
$69.00 /

+1.46 (+2.16%)

  • 21
    Oct
BRKR Bruker
$69.00 /

+1.46 (+2.16%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.